The third batch of national bid opened on August 20, the finalists up to 8 enterprises (with the highest valid declaration price)

On July 30, Shanghai Sunshine Pharmaceutical Procurement Network released the "National Organization Drug Centralized Procurement and Use Joint Procurement Office on the release of the National Drug Centralized Procurement Document (GY-YD2020-1)" (National Union Word (2020) No. 1), while the network announced the "Purchase Variety Catalog" "The first year of procurement agreement" and "the first year of procurement agreement for each procurement variety agreement."
the National Drug Centralized Procurement Document (GY-YD2020-1) (hereinafter referred to as the "Document"), it is pointed out that the number of enterprises with the largest number of finalists of the same variety in this procurement catalogue is determined by the number of declared enterprises that meet the "declaration of variety qualification", up to 8.
declaration information disclosure, supply area confirmation time and place is August 20, 2020 (Thursday) 10 a.m., Shanghai Mayor Ning District, Hongqiao Road 2419 Longbai Hotel Yunting Venue.
the injection procurement cycle only one year "document" pointed out that the drug centralized procurement cycle from the actual implementation of the results, in annual units.
the calculation base of the purchase volume agreed upon in the first year of each place shall be determined by the local authorities.
the first year of the agreement procurement volume and the first year of each procurement variety agreed purchase volume.
the first year of each variety of the agreed purchase volume is determined according to the following rules: the number of actual enterprises in the country is 1, for the first year the agreed purchase volume calculation base of 50%;
among them amoxicillin granules, linaimine oral change agent type, mosisac sodium chloride injection, left oxyfluorasin oral pascoe eye drops, cephalosporini oral pascoa release agent type, cephalosporine oral frequent release agent type, kramycin oral asanophine type of first-year agreed purchase volume according to the following rules: national actual selection of the following rules The number of enterprises is 1, for the first year agreed to purchase volume calculation base of 40%;
on the procurement cycle, the document points out that the procurement cycle of each variety is determined according to the following rules: the actual number of selected enterprises in the country is 1 or 2, the current round of procurement cycle is in principle 1 year;
one of the asocytindine injections, moxisasin sodium chloride injections, left ethyl lasitan injection with a concentrated solution this round procurement cycle in principle is 1 year.
the purchase agreement is signed annually during the procurement cycle.
the renewal of the purchase agreement, the agreed purchase amount shall not in principle be less than the purchase amount agreed upon in the previous year of the selected drug in various places.
if the purchase period in advance of the completion of the current year's agreed purchase volume, the excess selected enterprises will still be in accordance with the winning price for supply, until the purchase cycle expires.
will open the tender "document" in three weeks, the declaration of enterprise qualification for the provision of drugs and accompanying services of domestic pharmaceutical manufacturers, drug listing license holders, drug listing license holders (for foreign enterprises) designated the national general agent of imported drugs.
enterprises that meet the reporting requirements are required to submit their declarations at a specified time, and failure to do so will affect the centralized procurement activities of the drugs involved in the enterprise throughout the country.
listed drugs that fall within the scope of the catalogue of purchased varieties and obtain valid domestic registration approvals, and meet one of the following requirements, will be eligible for declared varieties: 1. The original research drug and the State Drug Administration issued the generic drug quality and efficacy consistency evaluation reference preparation; Imitation drugs approved by newly registered classification of chemical drugs, according to the "Announcement of the State Food and Drug Administration on the Work Programme for the Reform of the Registration and Classification of Chemical Drugs" (No. 51 of 2016), and 4. Drugs included in the List Of Drugs listed in China.
the Document, it is also pointed out that the declaring enterprise shall ensure that the procurement period meets the demand for the purchase volume of the selected drugs in the supply area within the procurement cycle, that the list of supply varieties shall include all the specifications of the enterprise produced in the catalogue of purchased varieties that meet the "qualification of declared varieties", and that it shall comply with the relevant laws and regulations such as the Patent Law, the Anti-Unfair Competition Law, etc. And bear the corresponding legal responsibilities; the declared drugs shall comply with the national drug standards and the quality standards of drugs approved by the State Drug Administration, and organize production in accordance with the circular of the Drug Administration Drug Administration of the State on the issuance of the Technical Guidelines for the Study of Nitrosamines in Central Asia (Trial) (No. 1 of 2020). The joint procurement office of the
will begin receiving the declaration materials at 7:30 a.m. on Thursday, August 20, at the Peony Hall of the Longbai Hotel at 2419 Longbai Hotel in Shanghai's Mayor's Ning District.
will be publicly declared after 10 p.m., and the supply area will be confirmed at 2 p.m. on the same day.
a catalogue of purchased varieties.